News - AVEO Pharmaceuticals

Filter

Current filters:

AVEO Pharmaceuticals

Popular Filters

AVEO Pharma licenses RON-targeted antibodies to Johnson & Johnson unit for up to $555 million

01-06-2011

In a second significant deal this year, US cancer drug developer AVEO Pharmaceuticals (Nasdaq: AVEO)…

AVEO PharmaceuticalsCentocor Ortho BiotechJohnson & JohnsonLicensingOncologyPharmaceutical

Back to top